Dr. Laura Jane Spranklin, DO

Dr. Spranklin practices at The University of Tennessee Medical Center in Knoxville, Tennessee, part of Ut Medical.

Dr. Spranklin's NPI, 1669792586, was assigned on June 2, 2010. Dr. Spranklin graduated from Lake Erie College of Osteopathic Medicine, Erie in 2010. Dr. Spranklin holds Tennessee license 3033.

Dr. Spranklin's primary practice is The University of Tennessee Medical Center, at 1924 Alcoa Highway, Knoxville, TN 37920 in Knox County. The practice phone is (865) 305-9000.

Dr. Spranklin's primary practice is The University of Tennessee Medical Center in Knoxville, Tennessee, part of Ut Medical. Dr. Spranklin is also affiliated with Covenant Health Parkwest. The medical group on file is UT Internal Medicine - Pellissippi. Dmand AI also links Dr. Spranklin to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Spranklin practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Spranklin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Spranklin's licenses on file in 2 states: Tennessee and Pennsylvania.

CMS data shows 603 Medicare services from Dr. Spranklin across 4 procedure codes in 2024, all of them office visits, for 212 Medicare patients. Medicare paid $52,976 for them.

CMS counts 212 Medicare patients who saw Dr. Spranklin in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Spranklin's median patient age at 72, with 65% women.

In 2024, Dr. Spranklin wrote 654 Medicare Part D claims for 149 patients. 76% of them were for generic drugs. CMS names the drug for 398 of them, across 16 drugs with 11 or more claims each, at $555,053 in total drug cost. In 2023, CMS named 389 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Spranklin for performance year 2024, reported through an alternative payment model (APM). Dr. Spranklin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 236 general payments to Dr. Spranklin from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 72% of the total. Pfizer Inc. paid the most, $613.

Dr. Spranklin graduated from Lake Erie College of Osteopathic Medicine, Erie in 2010.